MoneyMuscle: Which Stocks to Buy and Why

Wise Travel FY26 Result: PAT up 26%, Strong FY27 Guidance

Guides for 35-40% revenue growth outlook with improving margins. After a strong FY26 Wise Travel is trading at cheap current and forward valuations

Oct 11

3

OSEL Devices FY26 Result: PAT up 630%, Strong FY27 Guidance

Guides for 57% revenue growth for FY27 with stable to improving margins. After a strong FY26 OSEL is trading at reasonable valuations with a FY27…

Oct 4

6

September 2026

Sanghvi Movers Q1 FY27 Result: PAT up 630%, Strong FY27 Guidance

Guides for 30% revenue CAGR for FY26-FY28. Strong Q1 FY27 by Sanghvi Movers pointing to possibility to beat FY26 guidance. Trading at attractive forward…

Sep 27

3

Uflex Q1 FY27 Result: PAT up 630%, Strong FY27 Guidance

Guides for 35% revenue CAGR for FY26-FY28. Uflex is show signs of turnaround after years of weak performance. Trading at attractive valuations

Sep 20

3

NSE IPO Review: Is ₹1,785 a Fair Price?

NSE IPO review at ₹1,700–₹1,785: financials, TTM P/E, free cash flow yield, NSE vs BSE and global peer valuation.

Sep 13

9

1

Best Public Sector Bank Stocks After Q1 FY27 Results: 12 Banks Compared

Which public sector bank stocks look strongest after Q1 FY27? We rank 12 banks on growth, ROA, asset quality, capital strength and valuation.

Sep 6

11

1

1

August 2026

Yatharth Hospital Q1 FY27 Result: PAT up 8%, Strong FY27 Guidance

Guides for ~40% revenue CAGR for FY27-FY29 with stable margins. Strong outlook of increasing capacity to 5000 beds. Available at reasonable forward…

Aug 30

4

Sky Gold Q1 FY27 Result: Profit Up 141%, Ahead FY27 Guidance

Guidance of 35% PAT CAGR for FY26-30. SKYGOLD at attractive forward valuation with potential for re-rating of multiples. Opportunity to ~2x based on…

Aug 23

3

1

DSM Fresh Foods Q1 FY27: Revenue up 58%, Strong Guidance till FY28

Guidance of 70-80% Revenue CAGR for FY26-28 with margin expansion. Solid Q1 FY27. DSM Fresh Foods trading at extremely cheap current and forward…

Aug 16

5

1

Deep Industries Q4 FY27 Result: PAT up 44%, On-track FY27 guidance

PAT CAGR of 58% for FY26-28. Revenue growth of 25-30%. Order-book provides visibility till FY28. After a solid Q1 FY27 trading at attractive forward…

Aug 9

6

Shadowfax Technologies Q1 FY27 Result: PAT up 716%, Upgraded Guidance for FY27

Guiding ~40% revenue growth with expanding margins till FY29. Opportunity exists on forward valuations. Risk if growth till FY28 not delivered as per…

Aug 2

4

July 2026

SG Finserve Q1FY27 Results: PAT up 119%, On-track FY27 Guidance

PAT CAGR of 30-35%. AUM CAGR of 30-35%. Trading at premium valuations after strong Q1 results. Opportunity of upside if longer term guidance is…

Jul 26

2